Coya Therapeutics Has Several Near-Term Share Price Appreciation Catalysts
Coya Therapeutics (COYA) is a clinical-stage company developing treatments for neurodegenerative diseases, including Amyotrophic Lateral Sclerosis ("ALS"), Alzheimer's disease ("AD"), Parkinson's disease ("PD"), and Frontotemporal Dementia ("FD"). Neurodegenerative diseases destroy brain cells, and the process is irreversible. Currently, available treat…
Keep reading with a 7-day free trial
Subscribe to Microcap Opportunities to keep reading this post and get 7 days of free access to the full post archives.